Major Surgical or Invasive Procedure: Pericardiocentesis with temporary drain  History of Present Illness: HPI: 67-year-old w/ newly diagnosed metastatic non-small cell lung cancer, originally called in to ED after finding of pericardial effusion on ECHO.
SHe was admitted to the [**Hospital Unit Name **] service on [**2119-9-25**] for pericardial effusion and went to cath for drainage of 240 cc of serous fluid with relief of tamponade.
A drain was placed in the pericardial sac, with 9 cc of outpu per discussion with the CCU resident.
The drain was removed [**2119-9-29**] and she was transferred to the OMED for further oncologic mangement.
Pertinent Results: [**2119-9-25**] 08:18PM   K+-4.4 [**2119-9-25**] 08:10PM   GLUCOSE-103 UREA N-16 CREAT-0.8 SODIUM-132* POTASSIUM-4.6 CHLORIDE-94* TOTAL CO2-23 ANION GAP-20 [**2119-9-25**] 08:10PM   CK(CPK)-61 [**2119-9-25**] 08:10PM   CK-MB-NotDone cTropnT-<0.01 [**2119-9-25**] 08:10PM   WBC-8.7 RBC-3.90* HGB-12.0 HCT-35.2* MCV-90 MCH-30.7 MCHC-34.0 RDW-12.3 [**2119-9-25**] 08:10PM   NEUTS-73.5* LYMPHS-13.1* MONOS-6.7 EOS-5.9* BASOS-0.8 [**2119-9-25**] 08:10PM   PLT COUNT-448* [**2119-9-25**] 08:10PM   PT-13.3 PTT-24.4 INR(PT)-1.1  Echo [**9-25**]: Impression: Large pericardial effusion with right atrial collapse detected.
Pericardiocentesis was successfully performed in the catheterization lab and a drain was placed.
Following the procedure the drain continued to put out 9cc over 18 hours.
The drain was removed on the second day following percardiocentesis and the patient was transferred from the CCU to the OMED service.
Patient continued to do well following removal of the drain with pulsus paradoxicus ranging between 5-7mmHg.
On therapeutic cath, found to have sig tamponade -> s/p pericardiocentesis with post-procedure drain.
Patient monitored in CCU given post-procedure drain with limited (9 cc) output in 18 hrs.
Pt transferred to OMED for further oncologic mangement.
MICU course c/b [**Date Range **] and rising WBC count, treated for PNA, completed course of antibiotics.
2) Shortness of breath: Despite successful pericardiocentesis, patient continued to have shortness of breath and supplement oxygen requirement.
Therefore, the patient was started on antibiotic therapy for a presumed pneumonia.
She had a repeat ultrasound guided thoracentesis on [**2119-10-10**] at which time 1050ml of fluid was removed prior to the proceedure being terminated for [**Date Range **].
3) NSCLCa: She was started on Chemotherapy while in house for her NSCLCA.
Her first course of Taxol/Carboplatinum was on [**2119-9-29**], she tolerated the treatment well.
She had neutropenia requiring her to be placed on precautions and treated with GCSF.
Her WBC count resolved with GCSF treatment.
She had a dosage of Taxol chemotherapy on [**2119-10-9**].
Social work has been envolved with her discussing coping and her diagnosis.
On discharge she was started on Megace to encourage increased PO intake.
She was treated with tesillon perles, robitussin w/ codeine, hydrocodone syrup, and cepacol losenges.
5) Depression/Anxiety: While in the hospital she was continued on her outpatient regimen of Buspar, Paxil CR, and Ativan/Xanax as needed.
6) Oral thrush: While in the hospital she was found to have some oral thrush and was started on Nystatin swish and swallow.
It was determined that she had very poor PO intake of fluids and food.
She was started on IV fluid and developed worsening edema.
She responds well to bolus fluids as needed.
Medications on Admission: MEDICATIONS: Evista, Cipro which she is finishing for a UTI, Ambien for sleep, Wellbutrin, Paxil, Xanax, niacin for cholesterol, and iron for some anemia in the past.
Zolpidem Tartrate 5 mg Tablet Sig: 1-2 Tablets PO HS (at bedtime).
Raloxifene HCl 60 mg Tablet Sig: One (1) Tablet PO qd ().
Aspirin 81 mg Tablet, Delayed Release (E.C.)
Paxil CR 37.5 mg Tablet Sustained Release 24HR Sig: One (1) Tablet Sustained Release 24HR PO qd ().
Ferrous Sulfate 325 (65) mg Tablet Sig: One (1) Tablet PO QD (once a day).
Bupropion HCl 150 mg Tablet Sustained Release Sig: One (1) Tablet Sustained Release PO QAM (once a day (in the morning)).
Alprazolam 1 mg Tablet Sig: One (1) Tablet PO TID (3 times a day) as needed.
Benzonatate 100 mg Capsule Sig: One (1) Capsule PO TID (3 times a day).
Heparin Sodium (Porcine) 5,000 unit/mL Solution Sig: One (1) Injection TID (3 times a day).
Lorazepam 0.5 mg Tablet Sig: 1-2 Tablets PO Q4-6H (every 4 to 6 hours) as needed.
Oxycodone HCl 5 mg Tablet Sig: One (1) Tablet PO Q3H (every 3 hours) as needed.
Acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q6H (every 6 hours) as needed.
Guaifenesin 100 mg/5 mL Syrup Sig: 5-10 MLs PO Q6H (every 6 hours) as needed.
Albuterol Sulfate 0.083 % Solution Sig: One (1)  Inhalation Q4H (every 4 hours).
Niacin 500 mg Capsule, Sustained Release Sig: Two (2) Capsule, Sustained Release PO BID (2 times a day).
Ipratropium Bromide 0.02 % Solution Sig: One (1)  Inhalation Q4H (every 4 hours).
Bisacodyl 5 mg Tablet, Delayed Release (E.C.)
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed for constipation.
Chlorpheniramine-Hydrocodone 8-10 mg/5 mL Suspension, Sust.
Calcium Carbonate 500 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO TID W/MEALS (3 TIMES A DAY WITH MEALS).
Nystatin 100,000 unit/mL Suspension Sig: Five (5) ML PO BID (2 times a day) as needed for oral thrush.
Menthol-Cetylpyridinium Cl 2 mg Lozenge Sig: One (1) Lozenge Mucous membrane  PRN (as needed).
Morphine Sulfate 10 mg/5 mL Solution Sig: One (1)  PO Q4-6H (every 4 to 6 hours) as needed for dyspnea.
